Table 1.
Patient characteristics.
| HIV | HIV/HCV | Chronic HCV | |
| Number (n) | 24 | 10 | 3 |
| Age (yrs ± SD) | 41.7 ± 7.0 | 39.2 ± 3.85 | 49 ± 15 |
| Sex (%) | |||
| M | 75 | 80 | 66 |
| F | 25 | 20 | 33 |
| HCV Genotype (%) | |||
| 1 | N/A | 100 | 0 |
| Non-1 | N/A | 0 | 0 |
| Unknown | N/A | 0 | 100 |
| HCV status (%) | |||
| Chronic infection (HCV RNA +) | N/A | 80 | 100 |
| Clearance (HCV RNA -) | N/A | 20 | 0 |
| HCV Risk Factor (%) | |||
| IVDU | N/A | 30 | 66.7 |
| Transfusion | N/A | 20 | 33.3 |
| Tattoo | N/A | 0 | 0 |
| Endemic area | N/A | 0 | 0 |
| Unknown | N/A | 40 | 0 |
| Estimated duration of infection (yrs ± SD)1 | |||
| HIV | 18 ± 5.1 | 10 ± 2.1 | N/A |
| HCV | N/A | 18 ± 3.4 | 24 ± 8 |
| Antiviral therapy (%) | |||
| HIV | 58 | 90 | N/A |
| HCV | N/A | 0 | 0 |
| Suppressed viral load2(%) | |||
| HIV | 75 | 70 | N/A |
| HCV | N/A | 20% | Unk. |
| CD4+ T cell count3 (median cells/μL, interquartile range) | 409, 422 | 608, 80 | N/A |
| CD4+ T cell nadir4 (median cells/μL, interquartile range) | 252, 296 | 247, 350 | N/A |
Abbreviations: Avg average; N/A not applicable; SD standard deviation. 1The time since clinically confirmed infection or, in the case of HCV, high risk activity. 2Undetectable viral load by Roche Amplicor RT-PCR test for HIV and in house PCR for HCV at the time of participation. This also includes those who have spontaneously cleared the virus in the case of HCV. 3Measured on the day of participation. 4Lowest documented count over the course of followup.